Brendan Wallace has a lot on his mind lately. Wallace is the co-founder of Fifth Wall Ventures, a 9-year-old proptech venture ...

Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Weight-loss drug developer Metsera is targeting an up to $1.78 billion valuation in its initial public offering, the ARCH Venture Partners-backed biotech company said on Monday. New York City-based ...

ARCH is one of the leading U.S. producers of high-quality metallurgical coal (“met coal”). This is the kind of coal used for ...

If you have a tip about tech, startups or the venture industry, contact Troy Wolverton at [email protected] or via ...

The deal would value the firm at about $2 billion and mark the latest push by private equity into the industry.

After a frenetic first couple of weeks as far as big rounds go, this week was quieter than a library. Only one round of more ...

Reports suggest that markets are projected to bounce back, making 2025 one of the strongest years in recent memory for ...

Discover how shrinking markets are forcing VCs to adapt. Will they stick to local ecosystems or compete globally to retain ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...